Capricor Therapeutics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $11,131 | $2,262 |
Gross Profit | -486 | -405 | 10,755 | 1,900 |
EBITDA | -25,925 | -24,577 | -7,322 | -12,649 |
EBIT | -26,412 | -24,982 | -7,697 | -13,010 |
Net Income | -25,910 | -24,392 | -7,117 | -12,557 |
Net Change In Cash | 0 | 0 | 11,131 | 2,262 |
Free Cash Flow | -21,571 | -7,573 | -15,531 | -11,701 |
Cash | 23,241 | 28,794 | 11,286 | 68,377 |
Basic Shares | 45,709 | 45,637 | 35,219 | 33,090 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $22,270 | $25,178 | $2,551 | $244 |
Gross Profit | 20,845 | 24,109 | 1,857 | |
EBITDA | -41,140 | -23,009 | -29,164 | -20,693 |
EBIT | -42,565 | -24,078 | -29,697 | -20,938 |
Net Income | -40,467 | -22,288 | -29,020 | -20,023 |
Net Change In Cash | 22,270 | 25,178 | 2,551 | 244 |
Cost of Revenue | -25,282 | 2,219 | ||
Free Cash Flow | -41,534 | -27,644 | 1,556 | -18,005 |
Cash | 11,286 | 14,694 | 9,603 | 34,885 |
Basic Shares | 35,219 | 26,778 | 24,552 | 23,089 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.57 |
2025-03-31 | -$0.53 |
2024-12-31 | -$0.16 |
